Philadelphia Methadone Treatment

Subscribe Here To Have Your Clinic Featured in this space

Following payment completion, please email us the clinic information that will be displayed here.

methadone8c



Methadone and suboxone are readily available in Philadelphia for the treatment of chronic opioid addiction. Philadelphia has numerous area methadone clinics & drug treatment programs providing methadone replacement therapy and outpatient drug counseling. Also available through local approved doctors is suboxone film (containing buprenorphine) which offers effective relief from opioid withdrawal symptoms in most opioid-addicted individuals. Methadone.US has provided below a number of links to more information on methadone treatment, opioid dependence characteristics, recovery counseling, and recent job positions in U.S. methadone clinics.


Philadelphia Methadone Clinics
Family Center of Thomas Jefferson Univ
Specialized Program for Preg Women
1233 Locust Street, 4th Floor
Philadelphia, PA 19107
(215) 955-8577
Addiction Medicine and Health
Advocates Inc
928 Market Street
Philadelphia, PA 19107
(215) 923-4202
John F Kennedy Drug Treatment Clinic 907 North Broad Street
Philadelphia, PA 19123
(215) 235-5520
Girard Medical Center
Goldman Clinic
801 West Girard Avenue
Philadelphia, PA 19122
(215) 787-2080
Thomas Jefferson University
Narcotic Addiction Rehab Program
NE Corner of South 21st Street
Philadelphia, PA 19146
(215) 735-5979×241
Achievement Through Counseling and Trt
ACT II
1745 North 4th Street
Philadelphia, PA 19122
(215) 236-0100
Veterans Affairs Medical Center
Addictions Recovery Unit
3900 Woodland Avenue
Philadelphia, PA 19104
(215) 823-6090
PA Veterans Affairs Med Ctr (PVAMC)
Substance Abuse Treatment Center
3900 Woodland Avenue, Building 3
Philadelphia, PA 19104
(215) 823-4300
Camden Treatment Associates
T/A Urban Treatment Associates
424 Market Street, Suite 32
Camden, NJ 08102
(856) 338-1811
Philadelphia VA Medical Center
Opiate Treatment Unit
39th and Woodland Avenue
Philadelphia, PA 19104
(215) 823-5809×6090

 

Philadelphia Buprenorphine Treatment
PA Veterans Affairs Med Ctr (PVAMC)
Substance Abuse Treatment Center
University and Woodland Avenues
Philadelphia, PA 19104
(215) 823-4300
Addiction Medicine and Health
Advocates Inc (AMHA)
1200 Walnut Street
2nd Floor
Philadelphia, PA 19107
(215) 545-8078×105
Intake:
(215) 545-8078×101
Interim House Inc 333 West Upsal Street
Philadelphia, PA 19119
(215) 849-4606
Intake:
(215) 849-4606×212
Girard Medical Center
Goldman Methadone Clinic
8th and Girard Avenue
Philadelphia, PA 19122
(215) 787-2000×2409
Fairmount Behavioral Health System 561 Fairthorne Avenue
Philadelphia, PA 19128
(215) 487-4000×4000
Parkside Recovery 5000 Parkside Avenue
Philadelphia, PA 19131
(215) 879-6116
Intake:
(215) 879-6116×222
Northeast Treatment Centers
Net Steps
2205 Bridge Street
Philadelphia, PA 19137
(215) 743-6150
 
Carla Rodgers, M.D. Two Penn Center
Suite 200
Philadelphia, PA 19102
(724) 591-5236
Ben Peter Jagiello, M.D. Two Penn Center
Suite 200
Philadelphia, PA 19102
(724) 591-5236
Frank Alfred Kunkel, M.D. Two Penn Center
Suite 200
Philadelphia, PA 19102
(724) 591-5236
Richard M. Sobel, M.D. 1518 Walnut Street
Suite 1110
Philadelphia, PA 19102
(215) 731-1901
Donald John Kushon, M.D. Hahnemann Hospital
17306 Ncb, Ms 403
Philadelphia, PA 19102
(215) 762-1866
Michael D. Miller, M.D. 255 South 17th Street
Suite 1410
Philadelphia, PA 19103
(215) 545-8450
Michael J. McCarthy, M.D. 2400 Chestnut Street, Suite 1409
Philadelphia, PA 19103
(215) 567-4773
John L. Edwards, D.O. Nelson Medical Group
255 South 17th Street
Philadelphia, PA 19103
(215) 546-7049
Matthew L. Prowler, M.D. 3440 Market Street
Suite 200
Philadelphia, PA 19104
(215) 590-1119
Onuorah Umeh, M.D. 4237 Baltimore Avenue
Philadelphia, PA 19104
(215) 382-1040
Steven Howard Snyderman, M.D. 51 North 39th Street
Suite W241
Philadelphia, PA 19104
(215) 662-8600
Anil K Rai, M.D. Veterans Affairs Medical Center Philadel
3900 Woodland Ave 7th Floor Psychiatry
Philadelphia, PA 19104
(215) 823-5800
Michael Gliatto, M.D. Philadelphia Veterans Admin. Med Center
38th-Woodland Ave. 7thFloor MailStop116A
Philadelphia, PA 19104
(215) 823-4037
Gregg E. Gorton, M.D. Veterans Administration Medical Center
University & Woodland Avenues
Philadelphia, PA 19104
(215) 823-5800
Kyle M. Kampman, M.D. Univ. of Penn, Treatment Research Ctr.
3900 Chestnut Street
Philadelphia, PA 19104
(215) 222-3200×109

Federal Rules For Methadone Access Are Changing

The synthetic opioid, fentanyl, has led to an increase in overdose deaths in recent years. As many as 112,000 in the last year according to NPR. As a result, some physicians are pushing to make methadone more available to those who need it.

The Biden administration has created new federal rules for methadone treatment designed to widen access for more patients. In particular, the requirement of one year of active opioid addiction is being reduced to just 6 months of opioid addiction in order to become eligible to receive methadone.

There are about 2000 federally-approved opioid treatment programs (OTP) in the United States. Many thousands of patients are receiving life saving services from these clinics. Since COVID, many OTP clinics have made take home medication more accessible to those in early phases of treatment.

With illegal opiates still flooding the country, increasing access to opioid treatment and medication is easily justified. The question remains as to how local law enforcement can ultimately stem the flow of drugs into the community, as well as how youth can be educated to avoid risking first drug use.

Posted in Buprenorphine, Harm Reduction, Methadone, Methadone Clinics, Methadone Take Home, Opioid Treatment, Prescription Drugs, Suboxone | Tagged , | Comments Off on Federal Rules For Methadone Access Are Changing

How Bad Is Opioid Withdrawal

There is an informative video by Sarah Wakeman on the physical and psychological perils of severe opioid withdrawal. Sarah is a Medical Director at Mass General Brigham. They are an integrated health care system that conduct medical research, teaching, and patient care.

In the video, Sarah explains how opioid withdrawal can become so severe with diarrhea and vomiting that individuals can die from extensive dehydration. As physicial dependency progresses, the brain becomes increasingly imbalanced and unable to function without the presence of opioids.

When opioid withdrawal commences (usually 8-12 hours after last use), it becomes increasingly unbearable as the body is flushed with stress hormones. The withdrawal discomfort builds in intensity over days, and can last up to a week or more. For many, this withdrawal process feels akin to a severe case of the flu, but then potentially reaches levels of sickness even far beyond that.

In the video, Sarah goes on to discuss the benefits of methadone and buprenorphine in reducing severe withdrawal symptoms and in helping patients to ultimately not die from overdose. She also illuminates on how rational decision-making is so extremely difficult when struggling against the intense pain of opioid withdrawal.

Please check this video out, and share it with anyone you believe can benefit from its message.

Posted in Buprenorphine, Medication Assisted Treatment, Methadone, Methadone Clinics, Opiate Withdrawal, Opioid Treatment, Pain Management, Prescription Drugs, Suboxone | Tagged | Comments Off on How Bad Is Opioid Withdrawal

Helping Skeptics Understand Methadone

When it comes to addiction, reactions and opinions are often intense. Addiction is a devastating illness that can rapidly derail a person’s life, and seriously impact the lives of those around them.

Sadly, addiction leads people to behave in ways that make no sense to their family, friends, and co-workers. Therein lies an important part of the problem. Family feel confused, angry, and fearful as their loved one tumbles down the hill of active addiction.

When it comes to something as perplexing as drug addiction, grasping for answers is an understandable reflex for family and friends. What family often don’t comprehend is the power of physical dependency to opioids and the severe sickness that results from opioid withdrawal.

Family and others incorrectly assume that mere “choice” is all that’s needed to overcome the addiction. When the addict fails to remain drug free, harsh judgment by others usually follows.

Halting withdrawal sickness is a paramount step for an opioid addicted person. This cannot be overstated. As long as a person is suffering from severe opioid withdrawal, their ability to think and “choose” logically is greatly impaired.

Statistically, individuals who utilize medication-assisted treatment (like methadone) are far more likely to avoid incarceration, a continued downward spiral, or death by overdose. Medication assistance successfully removes debilitating withdrawal sickness so that the addicted person can experience greater clarity of thought and the ability to make more sound decisions that lead to improved quality of life.

If you are a skeptic about methadone or suboxone, you may think “they’re just trading one drug for another”. This is not true. People, once therapeutically stabilized on methadone or suboxone, do not get high from the medication. Health generally improves, and the person is able to function much better on the job and at home. This brings hope. It offers a new opportunity for further recovery.

When you care about a person’s survival, one more chance to help them can be quite valuable. Don’t let judgment or excessive skepticism get in the way. Medication-assistance in opioid recovery is effective for many people, and it has been the life saving next step that some never got the chance to take.

Posted in Methadone, Methadone Benefits, Methadone Clinics, Recovery, Suboxone | Tagged | Comments Off on Helping Skeptics Understand Methadone

Methadone Treatment in Oregon

Like most states, Oregon is in need of quality treatment options for opioid-addicted individuals who are ready for recovery.

This article, in the Hillsboro News-Times, features the recent approval by Washington County commissioners to add a new methadone clinic in Hillsboro, Oregon.

Acadia Healthcare is aiming to establish the new methadone clinic in Hillsboro in order to better serve the local community. Acadia already operate a mobile unit in the general area as well as a comprehensive treatment center (CTC) in nearby Tigard located about 20 miles away.

The commissioners voted 5-0 to approve the proposed site which will be on the local bus route thereby providing improved access. The article mentions that Oregon presently has 17 operational methadone clinics serving the state, where fentanyl, opiates, and other substances are causing a grave overdose crisis.

Having local opioid treatment available is a critically important step in saving lives and providing hope to patients and families. Methadone has been proven to decrease opioid use, reduce relapse risks & overdose deaths, as well as increase employment and overall health. Clinics offering medication-assisted treatment (MAT), like methadone and buprenorphine, are forging a new path to safety for those people once stuck in active addiction.

Posted in Acadia Healthcare, Addiction Treatment, Buprenorphine, Methadone, Methadone Clinics, Oregon Methadone Clinics, Suboxone | Tagged , , | Comments Off on Methadone Treatment in Oregon

Remote Observation of Methadone Dosing

There’s a new spin being proposed on the dispensing of methadone to Opioid Use Disorder (OUD) patients. A federally-funded project is underway between Scene Health and The University of Washington in which patients video themselves taking their daily methadone dose, and then submit that video to the treatment provider.

The project is evaluating this new modified approach that falls somewhere between in-person daily dosing and unsupervised take home dosing.

This new approach is currently being referred to as Video DOT (video direct observation therapy) and has been successfully implemented with other health issues including hepatitis C, asthma, and diabetes.

While this experiment seems appealing at first glance, it does raise legitimate questions about the ability to insure proper safety protocols with the provision of methadone medication to new patients. The project may possibly demonstrate the usefulness of Video DOT methadone dosing. But assuming this new approach one day becomes common practice, it will be important that physicians or clinics have in place a procedure for quickly reclaiming methadone doses that are not ingested on schedule.

Imagine a new patient receives 7 take home doses of methadone, but then only sends in the required video of their medication use on day one. At what point does the prescribing clinic intervene, and how will the unaccounted for doses be retrieved?

Approved Opioid Treatment Programs currently have “callback” procedures in which stable patients are randomly selected to return to their home clinic with their unused take home doses. This allows the clinic medical staff to perform a medication count, and it acts as a safeguard to insure patients are taking their medication as prescribed.

Patients who have earned take home privileges through months of treatment progress are less inclined to divert or misuse methadone than someone who just started treatment. New patients must be inducted gradually on a stabilizing dose of methadone. And time is typically needed to help these patients adjust to methadone while eliminating use of all other illicit substances. This is where the benefit of a structured treatment program is most relevant. OTP’s provide extremely valuable life management skills training in conjunction with medication therapy.

It remains to be seen if “easy access” to methadone is truly an advancement in care, or a step backwards in accountability & safety for patients and the public.

Posted in Medication Assisted Treatment, Methadone, Methadone Clinics, Methadone Programs, Suboxone, Suboxone Clinics | Tagged | Comments Off on Remote Observation of Methadone Dosing